Corient Private Wealth’s Kyverna Therapeutics KYTX Stock Holding History
Bought
Maintained
Sold
Other funds holding KYTX
ACM
Corient Private Wealth's KYTX Position: Q3 2026 in Review
Corient Private Wealth opened a new position in Kyverna Therapeutics (KYTX) in Q3 2026: 16,000 shares worth $109K. The stake represents ﹤0.01% of the portfolio and ranks #3130 among its holdings.
128 funds tracked by Wall St. Rank hold KYTX as of Q3 2026.
- Corient Private Wealth held 16,000 shares of Kyverna Therapeutics worth $109K as of Q3 2026.
- Kyverna Therapeutics was a new Corient Private Wealth position in Q3 2026.
- Kyverna Therapeutics made up ﹤0.01% of Corient Private Wealth's portfolio in Q3 2026, its #3130 holding.
- 128 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q3 2026.
Based on Corient Private Wealth's 13F filing for Q3 2026, filed 16 Nov 2026.